XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Operating activities    
Net income $ 148,388 $ 116,891
Adjustments to reconcile net income to net cash used in operating activities:    
Depreciation 12,888 11,617
Amortization 938 743
Share-based compensation 6,481 6,299
Equity earnings in unconsolidated investments, net (106) (78)
Other 1,861 2,122
Changes in operating assets and liabilities, net of effects of acquisitions:    
Receivables (210,327) (199,055)
Product inventories (76,286) (53,546)
Prepaid expenses and other assets 2,100 (2,389)
Accounts payable 55,964 38,673
Accrued expenses and other current liabilities 21,290 37,378
Net cash used in operating activities (36,809) (41,345)
Investing activities    
Acquisition of businesses, net of cash acquired (578) (3,296)
Purchase of property and equipment, net of sale proceeds (24,620) (34,495)
Other investments, net 0 3
Net cash used in investing activities (25,198) (37,788)
Financing activities    
Proceeds from revolving line of credit 554,536 606,623
Payments on revolving line of credit (545,574) (641,752)
Proceeds from asset-backed financing 177,500 156,600
Payments on asset-backed financing (60,000) (20,100)
Proceeds from short-term borrowings and current portion of long-term debt 13,957 22,609
Payments on short-term borrowings and current portion of long-term debt (3,330) (8,813)
Payments of deferred and contingent acquisition consideration (265) (199)
Payments of deferred financing costs (8) 0
Purchase of redeemable noncontrolling interest 0 (2,573)
Proceeds from stock issued under share-based compensation plans 9,383 7,502
Payments of cash dividends (33,194) (28,108)
Purchases of treasury stock (38,876) (8,672)
Net cash provided by financing activities 74,129 83,117
Effect of exchange rate changes on cash and cash equivalents 105 726
Change in cash and cash equivalents 12,227 4,710
Cash and cash equivalents at beginning of period 29,940 21,956
Cash and cash equivalents at end of period $ 42,167 $ 26,666